{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:02:53Z","timestamp":1787022173340,"version":"build-2736575974"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LQ24H160021"],"award-info":[{"award-number":["LQ24H160021"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>This study focuses on the development and optimization of S11a-0000168202, a novel LIMK1 inhibitor with potential therapeutic applications in gastric cancer. Through scaffold hopping and structural modification of HIT100844099, S11a-0000168202 demonstrated enhanced binding stability and stronger interactions with key LIMK1 residues, including GLU-414, ILE-416, and HIS-464. Molecular dynamics simulations and MMGBSA analyses confirmed the compound\u2019s stability, while ADMET evaluation revealed favorable properties such as moderate lipophilicity, good human intestinal absorption, and low P-glycoprotein inhibition. Despite the promising computational results, the lack of experimental validation remains a limitation. Future studies should focus on in vitro and in vivo testing to confirm S11a-0000168202\u2019s efficacy, pharmacokinetics, and safety. This compound holds significant potential as a therapeutic agent for LIMK1-targeted gastric cancer treatment.<\/jats:p>","DOI":"10.1371\/journal.pone.0323699","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T13:34:59Z","timestamp":1747229699000},"page":"e0323699","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Design, optimization, and ADMET evaluation of S11a-0000168202: A promising LIMK1 inhibitor for gastric cancer treatment"],"prefix":"10.1371","volume":"20","author":[{"given":"Guojun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jionghuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4407-6703","authenticated-orcid":true,"given":"Weihua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"issue":"5","key":"pone.0323699.ref001","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","article-title":"Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention","volume":"20","author":"AP Thrift","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"pone.0323699.ref002","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/jso.26869","article-title":"Environmental and genetic risk factors for gastric cancer","volume":"125","author":"D Shah","year":"2022","journal-title":"J Surg Oncol"},{"issue":"3","key":"pone.0323699.ref003","doi-asserted-by":"crossref","first-page":"200857","DOI":"10.1016\/j.omton.2024.200857","article-title":"Unveiling promising targets in gastric cancer therapy: A comprehensive review","volume":"32","author":"W Li","year":"2024","journal-title":"Mol Ther Oncol"},{"issue":"1","key":"pone.0323699.ref004","doi-asserted-by":"crossref","first-page":"188549","DOI":"10.1016\/j.bbcan.2021.188549","article-title":"HER2-targeted therapies in gastric cancer","author":"Y Zhu","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"pone.0323699.ref005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12935-025-03655-8","article-title":"A literature review of recent advances in gastric cancer treatment: exploring the cross-talk between targeted therapies","volume":"25","author":"R Panahizadeh","year":"2025","journal-title":"Cancer Cell Int"},{"key":"pone.0323699.ref006","doi-asserted-by":"crossref","first-page":"107695","DOI":"10.1016\/j.bioorg.2024.107695","article-title":"Advances in HER2-Targeted Therapies: From monoclonal antibodies to dual inhibitors developments in cancer treatment","volume":"151","author":"M Bhagyalalitha","year":"2024","journal-title":"Bioorg Chem"},{"issue":"1","key":"pone.0323699.ref007","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41419-023-06389-5","article-title":"Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks","volume":"15","author":"L Meng","year":"2024","journal-title":"Cell Death Dis"},{"key":"pone.0323699.ref008","doi-asserted-by":"crossref","first-page":"1450339","DOI":"10.3389\/fchem.2024.1450339","article-title":"Computational identification and analysis of CNP0269688 as a natural product inhibitor disrupting the interaction between the HIV matrix domain and tRNA","volume":"12","author":"C Xu","year":"2024","journal-title":"Front Chem"},{"issue":"14","key":"pone.0323699.ref009","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1038\/s41388-021-01736-2","article-title":"LIMK1 nuclear translocation promotes hepatocellular carcinoma progression by increasing p-ERK nuclear shuttling and by activating c-Myc signalling upon EGF stimulation","volume":"40","author":"Z Pan","year":"2021","journal-title":"Oncogene"},{"key":"pone.0323699.ref010","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1038\/s41388-021-01656-1","article-title":"LIMK1 promotes peritoneal metastasis of gastric cancer and is a therapeutic target","volume":"40","author":"X Kang","year":"2021","journal-title":"Oncogene"},{"key":"pone.0323699.ref011","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2020-1796","article-title":"Requirement for LIM kinases in acute myeloid leukemia","volume":"80","author":"P Jensen","year":"2020","journal-title":"Cancer Res"},{"key":"pone.0323699.ref012","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.advms.2023.04.002","article-title":"Inhibition of airway smooth muscle contraction and proliferation by LIM kinase inhibitor LIMKi3","volume":"68","author":"N Li","year":"2023","journal-title":"Adv Med Sci"},{"issue":"3","key":"pone.0323699.ref013","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bcmd.2007.01.002","article-title":"Lysophosphatidic acid stimulation of platelets rapidly induces Ca2+-dependent dephosphorylation of cofilin that is independent of dense granule secretion and aggregation","volume":"38","author":"D Pandey","year":"2007","journal-title":"Blood Cells Mol Dis"},{"issue":"7","key":"pone.0323699.ref014","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1078\/0171-9335-00382","article-title":"LIM kinase 1: evidence for a role in the regulation of intracellular vesicle trafficking of lysosomes and endosomes in human breast cancer cells","volume":"83","author":"Y Nishimura","year":"2004","journal-title":"Eur J Cell Biol"},{"issue":"11","key":"pone.0323699.ref015","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1002\/ijc.21650","article-title":"LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase-type plasminogen activator system","volume":"118","author":"R Bagheri-Yarmand","year":"2006","journal-title":"Int J Cancer"},{"key":"pone.0323699.ref016","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","article-title":"Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy","volume":"470","author":"X Lei","year":"2020","journal-title":"Cancer Lett"},{"issue":"1","key":"pone.0323699.ref017","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3892\/ol.2022.13354","article-title":"LIMK1: A promising prognostic and immune infiltration indicator in colorectal cancer","volume":"24","author":"X Liu","year":"2022","journal-title":"Oncol Lett"},{"issue":"20","key":"pone.0323699.ref018","doi-asserted-by":"crossref","first-page":"13705","DOI":"10.1021\/acs.jmedchem.2c00751","article-title":"Comparative Analysis of Small-Molecule LIMK1\/2 Inhibitors: Chemical Synthesis, Biochemistry, and Cellular Activity","volume":"65","author":"R Collins","year":"2022","journal-title":"J Med Chem"},{"issue":"18","key":"pone.0323699.ref019","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1016\/j.bmcl.2015.07.009","article-title":"Design, synthesis and biological characterization of selective LIMK inhibitors","volume":"25","author":"S Boland","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"pone.0323699.ref020","article-title":"Computer-aided drug design and drug discovery: a prospective analysis","volume":"17","author":"S Niazi","year":"2024","journal-title":"Pharmaceutics"},{"key":"pone.0323699.ref021","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106324","article-title":"CADD, AI and ML in drug discovery: a comprehensive review","volume":"181","author":"D Vemula","year":"2023","journal-title":"Eur J Pharm Sci"},{"key":"pone.0323699.ref022","doi-asserted-by":"crossref","first-page":"13264","DOI":"10.1021\/acs.jmedchem.2c01106","article-title":"Development and characterization of type I, type II, and type III LIM-kinase chemical probes","volume":"65","author":"T Hanke","year":"2022","journal-title":"J Med Chem"},{"issue":"3","key":"pone.0323699.ref023","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"GM Sastry","year":"2013","journal-title":"J Comput Aided Mol Des"},{"key":"pone.0323699.ref024","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10822-010-9349-1","article-title":"Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution","volume":"24","author":"JR Greenwood","year":"2010","journal-title":"J Comput Aided Mol Des"},{"issue":"7","key":"pone.0323699.ref025","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space","volume":"17","author":"C Lu","year":"2021","journal-title":"J Chem Theory Comput"},{"issue":"1","key":"pone.0323699.ref026","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ci100275a","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations","volume":"51","author":"T Hou","year":"2011","journal-title":"J Chem Inf Model"},{"issue":"10","key":"pone.0323699.ref027","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1021\/ci2002704","article-title":"Rapid shape-based ligand alignment and virtual screening method based on atom\/feature-pair similarities and volume overlap scoring","volume":"51","author":"GM Sastry","year":"2011","journal-title":"J Chem Inf Model"},{"issue":"8","key":"pone.0323699.ref028","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10822-016-9959-3","article-title":"ROCS-derived features for virtual screening","volume":"30","author":"S Kearnes","year":"2016","journal-title":"J Comput Aided Mol Des"},{"issue":"43","key":"pone.0323699.ref029","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1021\/jp003020w","article-title":"Structure and Dynamics of the TIP3P, SPC, and SPC\/E Water Models at 298 K","volume":"105","author":"P Mark","year":"2001","journal-title":"J Phys Chem A"},{"key":"pone.0323699.ref030","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1021\/jp9518623","article-title":"Calculating electrostatic interactions using the particle-particle particle-mesh method with nonperiodic long-range interactions","volume":"100","author":"BA Luty","year":"1996","journal-title":"J Phys Chem"},{"key":"pone.0323699.ref031","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1021\/ja512751q","article-title":"Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force field","volume":"137","author":"L Wang","year":"2015","journal-title":"J Am Chem Soc"},{"issue":"2","key":"pone.0323699.ref032","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s12274-021-3696-1","article-title":"Intramolecular hydrogen bonds in a single macromolecule: Strength in high vacuum versus liquid environments","volume":"15","author":"W Cai","year":"2021","journal-title":"Nano Res"},{"issue":"5","key":"pone.0323699.ref033","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3390\/cells12050805","article-title":"LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features","volume":"12","author":"E Villalonga","year":"2023","journal-title":"Cells"},{"issue":"5","key":"pone.0323699.ref034","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/s41416-020-01156-1","article-title":"Cysteine metabolic circuitries: druggable targets in cancer","volume":"124","author":"VDB Bonif\u00e1cio","year":"2021","journal-title":"Br J Cancer"},{"issue":"4","key":"pone.0323699.ref035","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/cbdd.14277","article-title":"Molecular docking-based virtual screening and dynamics simulation study of novel and potential SIRT7 inhibitors","volume":"102","author":"X Guo","year":"2023","journal-title":"Chem Biol Drug Des"},{"key":"pone.0323699.ref036","doi-asserted-by":"crossref","first-page":"1441550","DOI":"10.3389\/fmolb.2024.1441550","article-title":"Discovery of an 8-oxoguanine regulator PCBP1 inhibitor by virtual screening and its synergistic effects with ROS-modulating agents in pancreatic cancer","volume":"11","author":"K Qiao","year":"2024","journal-title":"Front Mol Biosci"},{"key":"pone.0323699.ref037","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122004","article-title":"The caco-2 model: modifications and enhancements to improve efficiency and predictive performance","volume":"624","author":"N Panse","year":"2022","journal-title":"Int J Pharm"},{"issue":"31","key":"pone.0323699.ref038","doi-asserted-by":"crossref","first-page":"19007","DOI":"10.1039\/C6RA28442F","article-title":"Predicting human intestinal absorption with modified random forest approach: a comprehensive evaluation of molecular representation, unbalanced data, and applicability domain issues","volume":"7","author":"N-N Wang","year":"2017","journal-title":"RSC Adv"},{"issue":"6","key":"pone.0323699.ref039","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09777","article-title":"P-glycoprotein: new insights into structure, physiological function, regulation and alterations in disease","volume":"8","author":"II Ahmed Juvale","year":"2022","journal-title":"Heliyon"},{"issue":"12","key":"pone.0323699.ref040","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1080\/17460441.2021.1961741","article-title":"An update on the importance of plasma protein binding in drug discovery and development","volume":"16","author":"L Di","year":"2021","journal-title":"Expert Opin Drug Discov"},{"issue":"1","key":"pone.0323699.ref041","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood-brain barrier: structure, regulation, and drug delivery","volume":"8","author":"D Wu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"pone.0323699.ref042","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1007\/s00204-020-02936-7","article-title":"Inhibition and induction of CYP enzymes in humans: an update","volume":"94","author":"J Hakkola","year":"2020","journal-title":"Arch Toxicol"},{"key":"pone.0323699.ref043","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2023.108405","article-title":"Structural analysis of hERG channel blockers and the implications for drug design","volume":"120","author":"S AlRawashdeh","year":"2023","journal-title":"J Mol Graph Model"},{"issue":"2","key":"pone.0323699.ref044","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1021\/ct5010615","article-title":"WESTPA: an interoperable, highly scalable software package for weighted ensemble simulation and analysis","volume":"11","author":"MC Zwier","year":"2015","journal-title":"J Chem Theory Comput"},{"issue":"4","key":"pone.0323699.ref045","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1021\/acs.jctc.2c00282","article-title":"DeepWEST: Deep Learning of Kinetic Models with the Weighted Ensemble Simulation Toolkit for Enhanced Sampling","volume":"19","author":"AA Ojha","year":"2023","journal-title":"J Chem Theory Comput"},{"issue":"9","key":"pone.0323699.ref046","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1021\/acs.jctc.0c00395","article-title":"Ligand Gaussian Accelerated Molecular Dynamics (LiGaMD): Characterization of Ligand Binding Thermodynamics and Kinetics","volume":"16","author":"Y Miao","year":"2020","journal-title":"J Chem Theory Comput"},{"issue":"12","key":"pone.0323699.ref047","doi-asserted-by":"crossref","first-page":"7938","DOI":"10.1021\/acs.jctc.1c00770","article-title":"Gaussian-Accelerated Molecular Dynamics with the Weighted Ensemble Method: A Hybrid Method Improves Thermodynamic and Kinetic Sampling","volume":"17","author":"S-H Ahn","year":"2021","journal-title":"J Chem Theory Comput"},{"issue":"17","key":"pone.0323699.ref048","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1021\/acs.jctc.3c00660","article-title":"Kinetics from Metadynamics: Principles, Applications, and Outlook","volume":"19","author":"D Ray","year":"2023","journal-title":"J Chem Theory Comput"},{"issue":"15","key":"pone.0323699.ref049","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1021\/acs.jpcb.6b09388","article-title":"Seekr: simulation enabled estimation of kinetic rates, a multiscale approach to predicting molecular kinetics","volume":"121","author":"L Votapka","year":"2017","journal-title":"J Phys Chem B"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0323699","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T13:35:09Z","timestamp":1747229709000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0323699"}},"subtitle":[],"editor":[{"given":"Yusuf Oloruntoyin","family":"Ayipo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0323699","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]}}}